Freeflow Ventures is hosting a discussion on the translation of academic science – in this case human health sciences – into commercial success and practical application. President Emeritus of Caltech, Nobel Laureate, and Freeflow portfolio company co-founder David Baltimore will provide his uniquely deep and broad perspective as an institutional leader, company creator, and bench researcher. We’ll also be joined by Freeflow founders from portfolio companies in human health sharing their translational founder stories. Finally, we’ll take questions from the audience.
Watch now to learn more about how we’re translating science into innovation!
Other articles
December 19, 2025
Iambic Therapeutics: Inside the Company Advancing and Accelerating AI in Drug Development
How does a techbio company get to clinic faster and scale a platform business?…
December 16, 2025
From Science to Startup – Freeflow Scientific Advisory Board Insights from Caltech & Berkeley
From Science to Startup: Insights from Caltech and Berkeley featuring: Barbara…
March 14, 2025
Flion Energy: Powering the New Geothermal
Flion Energy is a Freeflow Fund One portfolio company developing novel…



